- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04583579
Maximizing the Initial Experience of a Neophyte Scleral Lens Wearer
July 15, 2024 updated by: Andrew Pucker, University of Alabama at Birmingham
The goal of this proposal is to conduct a randomized controlled study aimed at learning the best method for applying scleral lenses and factors associated with successfully completing scleral lens application and removal training.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Scleral lens (SL) prescribing has dramatically increased over the past few years likely because of the advent of better SL designs, better materials, and greater awareness of the technology.
SL market growth has also likely increased because SLs were once reserved for patients with complex ocular surface diseases, though advances with SL technologies have allowed SL fitting to include patients with dry eye and even patients who have relatively uncomplicated refractive errors.
While SLs are maintained and cared for much like soft contact lenses (e.g., they require a contact lens care system), SL wearers also need help with applying their lenses.
Patients specifically are advised by their care provider to insert their SLs with their fingers (tripod method), a DMV inserter with an open or closed end (hole potentially aides in vision), or a specialized o-ring that is balanced on a finger.
Our clinic also utilizes a tea light candle with a DMV inserter attached to the top of it when patients have mobility issues.
While work from this investigator's study group has found that 54% of patients prefer DMV inserters for applying their SLs as compared to the above other options, these preliminary data were obtained through a cross-sectional electronic survey from subjects who completed their SL fitting up to two years ago.
Therefore, the goal of this proposal is to conduct a randomized controlled study aimed at learning the best method for applying SLs and factors associated with successfully completing SL application and removal training.
These data are needed because it will help practitioners with patient education and because it may increase the likelihood that patients will be successful with SLs.
Study Type
Interventional
Enrollment (Actual)
17
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35213
- University of Alabama at Birmingham
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adults (>18 years)
- Must have an indication for needing scleral lenses
Exclusion Criteria:
- Participating in another research study
- Unable to attend multiple visits
- Advanced knowledge or past use of scleral lenses
- A physical or mental condition that would prevent the subject from applying their own scleral lenses
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: New Scleral Lens Wearers
All patients will be asked to wear scleral lenses for the duration of this study.
|
This is a device used to help apply scleral lenses.
This is a device used to help apply scleral lenses.
This is a device used to help apply scleral lenses.
This is a device used to help apply scleral lenses.
This is a device used to help apply scleral lenses.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Scleral Lens Application Time
Time Frame: At Dispense Visit at Hour 0 (Visit 2)
|
Amount of time needed to apply scleral lenses to both eyes (minutes); each patient will try each application method in a random order.
|
At Dispense Visit at Hour 0 (Visit 2)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subject's Method Preference
Time Frame: At Dispense Visit at Hour 0 (Visit 2)
|
Patient top ranked preference of scleral lens application method (percent)
|
At Dispense Visit at Hour 0 (Visit 2)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 23, 2021
Primary Completion (Actual)
June 1, 2023
Study Completion (Actual)
June 1, 2023
Study Registration Dates
First Submitted
September 23, 2020
First Submitted That Met QC Criteria
October 5, 2020
First Posted (Actual)
October 12, 2020
Study Record Updates
Last Update Posted (Actual)
July 18, 2024
Last Update Submitted That Met QC Criteria
July 15, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB-300006015
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
We do not plan to sure individual participant data.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contact Lens Adaptation
-
EV Clinical TrialsCompletedContact Lens Discomfort | Contact Lens | Contact Lens DrynessUnited States
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
Aston UniversityCooperVision, Inc.Enrolling by invitationContact Lens Wear | Healthy Participants Study | Contact Lens FitUnited Kingdom
-
Ohio State UniversityCompletedContact LensUnited States
-
Ohio State UniversityAlcon ResearchCompleted
-
Ohio State UniversityAlcon ResearchCompleted
-
Glia, LLCCompletedContact Lens Discomfort | Contact Lens-induced Corneal Disorder | Contact Lens Acute Red Eye | Contact Lens-induced Corneal Fluorescein StainingUnited States
-
Ohio State UniversityAlcon ResearchCompleted
-
University Hospital, CaenNot yet recruitingContact Lens ComplicationFrance